169 related articles for article (PubMed ID: 11029492)
1. Telomerase activity and expression of apoptosis and anti-apoptosis regulators in the progression pathway of human melanoma.
Yang P; Becker D
Int J Oncol; 2000 Nov; 17(5):913-9. PubMed ID: 11029492
[TBL] [Abstract][Full Text] [Related]
2. Macroscopic spectral imaging and gene expression analysis of the early stages of melanoma.
Yang P; Farkas DL; Kirkwood JM; Abernethy JL; Edington HD; Becker D
Mol Med; 1999 Dec; 5(12):785-94. PubMed ID: 10666478
[TBL] [Abstract][Full Text] [Related]
3. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
Elder DE; Rodeck U; Thurin J; Cardillo F; Clark WH; Stewart R; Herlyn M
Cancer Res; 1989 Sep; 49(18):5091-6. PubMed ID: 2548711
[TBL] [Abstract][Full Text] [Related]
4. Increase in telomerase activity during progression of melanocytic cells from melanocytic naevi to malignant melanomas.
Glaessl A; Bosserhoff AK; Buettner R; Hohenleutner U; Landthaler M; Stolz W
Arch Dermatol Res; 1999; 291(2-3):81-7. PubMed ID: 10195394
[TBL] [Abstract][Full Text] [Related]
5. Expression of cell cycle and apoptosis regulatory proteins and telomerase in melanocitic lesions.
Batinac T; Hadzisejdić I; Brumini G; Ruzić A; Vojniković B; Zamolo G
Coll Antropol; 2007 Jan; 31 Suppl 1():17-22. PubMed ID: 17469743
[TBL] [Abstract][Full Text] [Related]
6. Intercellular adhesion molecule 1 (ICAM-1) and bcl-2 are differentially expressed in early evolving malignant melanoma.
Collins KA; White WL
Am J Dermatopathol; 1995 Oct; 17(5):429-38. PubMed ID: 8599446
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of cultured human melanocytes isolated from different stages of tumor progression.
Herlyn M; Thurin J; Balaban G; Bennicelli JL; Herlyn D; Elder DE; Bondi E; Guerry D; Nowell P; Clark WH
Cancer Res; 1985 Nov; 45(11 Pt 2):5670-6. PubMed ID: 4053039
[TBL] [Abstract][Full Text] [Related]
8. hTERT expression in melanocytic lesions: an immunohistochemical study on paraffin-embedded tissue.
Fullen DR; Zhu W; Thomas D; Su LD
J Cutan Pathol; 2005 Nov; 32(10):680-4. PubMed ID: 16293180
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of BCL-2 in melanomas and intradermal nevi.
Saenz-Santamaría MC; Reed JA; McNutt NS; Shea CR
J Cutan Pathol; 1994 Oct; 21(5):393-7. PubMed ID: 7868749
[TBL] [Abstract][Full Text] [Related]
10. BRAF oncogenic mutations correlate with progression rather than initiation of human melanoma.
Dong J; Phelps RG; Qiao R; Yao S; Benard O; Ronai Z; Aaronson SA
Cancer Res; 2003 Jul; 63(14):3883-5. PubMed ID: 12873977
[TBL] [Abstract][Full Text] [Related]
11. Spontaneous regression of cutaneous melanoma in sinclair swine is associated with defective telomerase activity and extensive telomere erosion.
Pathak S; Multani AS; McConkey DJ; Imam AS; Amoss MS
Int J Oncol; 2000 Dec; 17(6):1219-24. PubMed ID: 11078808
[TBL] [Abstract][Full Text] [Related]
12. Expression of apoptosis regulators in cutaneous malignant melanoma.
Tang L; Tron VA; Reed JC; Mah KJ; Krajewska M; Li G; Zhou X; Ho VC; Trotter MJ
Clin Cancer Res; 1998 Aug; 4(8):1865-71. PubMed ID: 9717813
[TBL] [Abstract][Full Text] [Related]
13. Antiapoptotic bcl-2 and bcl-xL in advanced malignant melanoma.
Leiter U; Schmid RM; Kaskel P; Peter RU; Krähn G
Arch Dermatol Res; 2000 May; 292(5):225-32. PubMed ID: 10867810
[TBL] [Abstract][Full Text] [Related]
14. Expression of the inducible isoform of nitric oxide synthase in pigment cell lesions of the skin.
Ahmed B; Van Den Oord JJ
Br J Dermatol; 2000 Mar; 142(3):432-40. PubMed ID: 10735946
[TBL] [Abstract][Full Text] [Related]
15. Whole-genome expression profiling of the melanoma progression pathway reveals marked molecular differences between nevi/melanoma in situ and advanced-stage melanomas.
Smith AP; Hoek K; Becker D
Cancer Biol Ther; 2005 Sep; 4(9):1018-29. PubMed ID: 16251803
[TBL] [Abstract][Full Text] [Related]
16. Expression of AP-2alpha, c-kit, and cleaved caspase-6 and -3 in naevi and malignant melanomas of the skin. A possible role for caspases in melanoma progression?
Woenckhaus C; Giebel J; Failing K; Fenic I; Dittberner T; Poetsch M
J Pathol; 2003 Oct; 201(2):278-87. PubMed ID: 14517845
[TBL] [Abstract][Full Text] [Related]
17. The role of Bcl-2 family members in the progression of cutaneous melanoma.
Bush JA; Li G
Clin Exp Metastasis; 2003; 20(6):531-9. PubMed ID: 14598887
[TBL] [Abstract][Full Text] [Related]
18. Bcl2 and Bax expression in naevi and melanomas and their relation to ploidy status and proliferation.
Korabiowska M; Brinck U; Ruschenburg I; Schlott T; Droese M; Stachura J
Pol J Pathol; 1999; 50(1):17-21. PubMed ID: 10412270
[TBL] [Abstract][Full Text] [Related]
19. Loss of expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions.
Zembowicz A; Knoepp SM; Bei T; Stergiopoulos S; Eng C; Mihm MC; Stratakis CA
Am J Surg Pathol; 2007 Nov; 31(11):1764-75. PubMed ID: 18059235
[TBL] [Abstract][Full Text] [Related]
20. Role of the cystathionine γ lyase/hydrogen sulfide pathway in human melanoma progression.
Panza E; De Cicco P; Armogida C; Scognamiglio G; Gigantino V; Botti G; Germano D; Napolitano M; Papapetropoulos A; Bucci M; Cirino G; Ianaro A
Pigment Cell Melanoma Res; 2015 Jan; 28(1):61-72. PubMed ID: 25205294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
